Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises when Lendify, a fintech company and one of Sweden’s largest challengers to the banking sector, completes a share issue of SEK 148m
Mandate

Vinge advises when Lendify, a fintech company and one of Sweden’s largest challengers to the banking sector, completes a share issue of SEK 148m

April 22, 2020 M&A

Vinge has advised Lendify AB (publ) (”Lendify”) in connection with raising of capital from new and current shareholders in an investment round in a total amount of approximately SEK 148 million.

The issue occurs at a valuation of Lendify of approximately SEK 1.5 billion (prior to the investment).

Vinge’s team primarily consisted of partner Jonas Johansson together with associates Filip Öhrner, Anna Thoms and Hanna Risberg.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025